ESRX

Ride the Reversal in Express Scripts

September's profit taking in Express Scripts has finally waned, and a bounce in ESRX appears likely. Here's my target for traders. More 

4 Healthcare Investments to Make Before October

With open enrollment in state health insurance exchanges set to kick off on Oct. 1, it’s a good time to revisit the ways investors can play the opportunity. More 

Facebook Makes the Grade and Is Now a Buy

Yes, you read that correctly. After spending months in sell territory, Facebook has made a complete turnaround in a matter of days and is now a buy More 

50 Reasons to Take the American Consumer Seriously

Power to the people. Specifically, the American consumer. There's a reason why the June retail sales report dominated the headlines: its a critical U.S. sector More 

Pharmacy Wars: Walgreens vs. CVS

The two largest U.S. pharmacy chains have both come roaring back, but which one -- CVS or Walgreens -- is the better bet for investors? Let's break it down. More 

48 Ways to Prepare for Earnings Season

Second-quarter earnings season is just around the corner and it's probably not going to turn any heads. Here's a preview of what to expect More 

What To Make Of Tuesday’s Surprising Market Move

Wall Street clearly made up for the shortened trading week with a broad rally on Tuesday. Here's our new research on 50 stocks in Portfolio Grader More